Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus

  • Rahbani A
  • Adwane G
  • Jomaa N
N/ACitations
Citations of this article
17Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 72-year-old man presented with a super-refractory partial status epilepticus following evacuation of a right subdural hematoma. He failed to respond to treatment with high doses of intravenous valproic acid, Levetiracetam, Lacosamide, Thiopental, and Midazolam. He was given 4 mg of Perampanel orally via nasogastric tube and the dose was rapidly increased to 8 mg after 12 hours with cessation of clinical and electrical seizures. Other antiepileptic drugs were tapered progressively with an excellent clinical outcome.

Cite

CITATION STYLE

APA

Rahbani, A., Adwane, G., & Jomaa, N. (2019). Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus. Case Reports in Neurological Medicine, 2019, 1–3. https://doi.org/10.1155/2019/8537815

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free